Head, US PA&PA Immunology

Sanofi•Washington, DC

2d•$232,500 - $335,833•Hybrid

About The Position

Sanofi is seeking a Head, US Public Affairs & Patient Advocacy (PA&PA) for Immunology. This role reports to the VP & Head, US Public Affairs & Patient Advocacy and is a member of the US PA&PA Leadership Team, Extended Leadership Teams of the US Immunology Business Unit, and Alliance PA&PA Governance. The position is hybrid with up to 25% travel, primarily domestic. Sanofi's mission is to ensure the US healthcare system understands and addresses patient needs, working with patient advocacy organizations to accelerate research, development, and access to medicines. The US PA&PA Immunology function aims to bridge the gap between disease onset and appropriate patient care, operating an outcome-driven advocacy model. The Head will lead this model and its evolution, overseeing Sanofi's immunology portfolio, including Dupixent and pipeline assets across various indications. The role requires deep therapeutic area leadership and enterprise-level contribution, including owning the US advocacy strategy, leading a team, managing budgets, and ensuring alignment with Corporate Affairs goals. The position is within the Specialty Care unit, focused on delivering breakthrough treatments for immune challenges, rare diseases, cancers, and neurological conditions.

Requirements

BA/BS in a scientific, public health, policy, or related field; advanced degree preferred.
15+ years of progressive experience in the biopharmaceutical industry or adjacent healthcare sectors.
7+ years in patient advocacy, public affairs, policy, or market access, including senior leadership of advocacy strategy
Demonstrated experience managing or leading through influence and developing high-performing teams of senior professionals, highly preferred.
Strategic fluency in the US patient access environment, Medicare dynamics, coverage design, utilization management, affordability, with the ability to anticipate how access forces will evolve, shape advocacy strategy around them, and engage as a senior peer with policy, government affairs, and market access leadership.
Demonstrated AI-native ways of working, uses AI tools daily as core instruments of strategy, analysis, writing, and decision-making rather than occasional aids; has redesigned personal and team workflows around AI; and can lead others through the same transformation.
Healthcare industry compliance experience, a working command of the compliance frameworks governing industry interactions with advocacy and healthcare organizations, including funding, grants, sponsorships, and transparency requirements, with a track record of operating impeccably within them.
Experience operating in complex, highly matrixed environments; alliance or partnership experience strongly preferred.

Nice To Haves

Enterprise-first leadership. Puts enterprise and patient outcomes first and represents the full breadth of Sanofi in every room.
Team players across boundaries. Works instinctively across functions, geography, and companies, US and global, Corporate Affairs and business, Sanofi and alliance partner, and builds followership through generosity, reliability, and shared credit.
Thrives in fast evolution. Energized rather than unsettled by a rapidly changing policy, competitive, and technology environment; adapts strategy at the pace the environment demands while keeping the team steady.
Outcomes discipline. A track record of managing through measures, setting outcome goals, stopping low-impact work, and demonstrating what changed for patients or systems, not what activities occurred.
Strategic judgment under ambiguity. Leads with a clear thesis, uses data and evidence to support decisions, and anticipates policy, competitive, and stakeholder shifts years ahead of launch.
Alliance and collaboration skills. Builds durable, principled partnerships across organizational boundaries; navigates complexity with discipline and protects long-term cooperation.
AI-native orientation. Treats AI as a default way of working, for insight generation, cross-disease learning, and decision support, and understands how emerging AI is changing healthcare delivery.
Cross-disease learning. Studies what works and why across therapeutic areas and applies it; contributes insight, failure, and best practice to organizational learning.
People development. Proven ability to coach professionals, grow next-generation leaders, and build succession depth, with development of others treated as a core leadership accountability, not a side activity.
Influence without authority. Earns trust and inspires action across external partners, business leadership, and global colleagues; distills complexity into clear, convincing communication for diverse audiences.

Responsibilities

Set and own the creation and execution of the US PA&PA Immunology strategy as a prioritized portfolio of priorities, each with explicit patient outcome measures.
Set the US PA&PA strategy for immunology, partner relationships, and patient-community understanding years before new treatment options may reach patients.
Use data, evidence, and the function's decision-support platforms to connect strategy, partnerships, programs, and outcomes.
Manage and be accountable for securing the US PA&PA budgets across dermatology, respiratory, rhinology, gastrointestinal, allergy, and pipeline immunology, ensuring disciplined planning, allocation, and full accountability for how advocacy resources are deployed.
Accountable for Sanofi's trusted partnerships with the US advocacy community across the immunology therapeutic area, owning the health, depth, and outcomes of relationships with patient advocacy organizations and professional societies, and earning continued partnership through transparency, consistency, and the quality of collaboration in service of shared patient priorities.
Bring senior fluency in the US patient access environment and translate its implications for patients into the function's advocacy strategy and priorities.
Stay ahead of how the advocacy environment is evolving, including the growing importance of digital and AI-era information channels to patient communities, and bring innovative approaches to how the function engages and learns.
Personally accountable for ensuring full compliance with healthcare contribution compliance requirements, alongside all corporate, industry, and regulatory guidelines; protect trust through ethics, transparency, and sound judgment under public scrutiny.
As a member of the US PA&PA Leadership Team, co-own functional strategy, talent, and operating-model decisions across all US therapeutic areas.
Serve as a standing member of the Extended Leadership Teams of the US Immunology Business Unit, carrying functional accountability across the franchises.
Integrate across Corporate Affairs, partnering with US Policy & Reimbursement, federal and state Government Affairs, communications, Health Equity, CSR, Global SPC Public Affairs, and Global SPC Communication, each within its own remit, to deliver one consistent Sanofi voice on immunology issues.
Partner with the Immunology Business Units and their General Managers, Market Access, PSS, Medical Affairs, HEVA, and R&D to embed patient insight upstream and align advocacy strategy with enterprise priorities.
Work closely with Global Public Affairs and country teams to inform global strategy with US insights and ensure global direction shapes US execution, serving as the US voice on immunology public affairs and patient advocacy in global forums.
Lead the US PA&PA interface with Regeneron across the Dupixent portfolio, operating a joint advocacy model with shared funding.
Provide senior-level alliance governance and stewardship, ensuring aligned advocacy strategy.
Lead, coach, and retain a team of US PA&PA leads covering dermatology, respiratory, rhinology, gastrointestinal disease, and Type 2 inflammation.
Treat developing others as a core leadership responsibility: provide individual coaching, career development, and stretch opportunities for each team member, growing the next generation of PA&PA leaders and ensuring the function's succession pipeline.
Develop the team's next capabilities, including digital and AI fluency, outcomes measurement, and cross-disease learning, building succession depth within a critical therapeutic area.
Model steady, principled leadership in a complex, fast-evolving environment, optimizing for patient outcomes and results.